Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000883626 | SCV001026948 | benign | not provided | 2018-03-29 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004028327 | SCV002630719 | likely benign | not specified | 2022-09-02 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV000883626 | SCV004125794 | likely benign | not provided | 2023-04-01 | criteria provided, single submitter | clinical testing | OBSCN: BP4, BS2 |
Breakthrough Genomics, |
RCV000883626 | SCV005281871 | benign | not provided | criteria provided, single submitter | not provided |